TRAITEMENT DES TROUBLES MÉTABOLIQUES CHEZ LES ÉQUIDÉS

• 收藏
• 分享

专利权人:

Boehringer Ingelheim Vetmedica GmbH

发明人:

申请号：

EP20172247.7

公开号：

EP3721882A1

申请日:

2015.03.30

申请国别(地区):

EP

年份:

2020

代理人:

摘要：

The present invention relates to one or more SGLT2 inhibitors or pharmaceutically acceptable forms thereof for use in the treatment and/or prevention of a metabolic disorder of an equine animal. In particular, the present invention relates to one or more SGLT2 inhibitors or a pharmaceutically acceptable form thereof for use in the treatment and/or prevention of laminitis, vascular dysfunction, hypertension, hepatic lipidosis, atherosclerosis, hyperadrenocorticism, Pituitary Pars Intermedia Dysfunction and/or Equine Metabolic Syndrome in an equine animal.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/